From bottled smoothies to kombucha, many of us are falling for great marketing and aesthetically pleasing packaging ...

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported a strong start to 2026 and reiterated its full-year outlook, pointing to ...

Ardelyx (ARDX) is rated Buy, driven by robust commercial execution of IBSRELA and XPHOZAH, and management's $1B revenue ...

Ardelyx (NASDAQ:ARDX) executives said the company entered 2026 with “another significant year of growth” underway, ...

Thermo Fisher Scientific, the world leader in serving science, will now manufacture drug product for Nuvation Bio in the United States Move by Nuvation Bio further ensures critical drug supply for ...

Senior developmental and farm journalist Shree Padre said here on Friday that although two government research institutes ...

(Chief Financial Officer Sue Hohenleitner) reported: “Our quarter-over-quarter total product revenues were $93.4 million compared to $67.8 million in the same period last year, representing 38% growth ...

Surveyed HCPs identified reduction of days on TPN as a top priority –– Improved quality of life, lower risk of infection and thrombosis viewed as key benefits of reduced TPN dependence –– Additional ...

Have you ever wanted to wish on a star? Now is your chance, the Eta Aquarids peak this week — and here’s your guide to making ...

Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth, leave and point solutions, today announced the expansion of its Alight Partner Network with the addition of ...

Entropy Neurodynamics has reported 75% of patients achieved clinically meaningful symptom improvement in treatment-resistant ...

VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader –– Approval received in advance of ...